v3.25.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

10. Commitments and contingencies

Lease commitments

The Company’s lease portfolio primarily comprises operating leases for office, laboratory, and manufacturing space. These leases contain various rent abatement periods, after which they require monthly lease payments that may be subject to annual increases throughout the lease term. Certain leases include options to extend the term. The renewal option is considered in the remaining lease term for the lease only when the Company is reasonably certain it will renew the lease. Certain leases provide the Company with the right to make tenant improvements, including the addition of laboratory space or build-out of manufacturing capabilities, and include a lease incentive allowance.

In June 2022, the Company entered into a lease agreement for 79,565 square feet of office, laboratory, and manufacturing space located in Bothell, Washington. The initial term of the lease expires in February 2039, with the option to extend the lease for up to three additional five-year terms. The lease agreement also provides for up to $19.9 million for reimbursement of tenant improvements, as well as an additional $8.0 million loan for tenant improvements, available at the Company’s election, which the Company would be obligated to repay to the landlord monthly over the initial term of the lease with interest at a rate of 6.5% per year (the Tenant Improvement Loan). The Company elected to receive the Tenant Improvement Loan in the second quarter of 2024. As of June 30, 2025, $0.4 million was included in accrued expenses and other current liabilities and $7.2 million was included in other non-current liabilities. The Company is obligated to pay base rent of approximately $68.8 million over the initial term of the lease. In accordance with the lease agreement, the Company has obtained a letter of credit in the amount of $1.6 million.

In the second quarter of 2025, the Company recognized non-cash impairment losses for the operating lease right-of-use (ROU) asset, construction in progress, and laboratory equipment for the Bothell facility, and for the operating lease ROU asset, leasehold improvements, and laboratory equipment for the Seattle facility. The Company also recognized additional non-cash impairment losses for other long-lived assets. Refer to Note 11, Impairment of long-lived assets for further information.

The following table contains additional information related to the Company’s operating leases:

 

Location

 

Use

 

Approximate
Square Footage

 

Commencement Dates

 

Expiration Dates

Seattle, WA

 

Office/Laboratory

 

48,000

 

March 2019 to September 2020

 

December 2026 to April 2028

Cambridge, MA

 

Office/Laboratory

 

56,000

 

March 2019 to January 2020

 

June 2027 to February 2028

South San Francisco, CA

 

Office/Laboratory

 

99,000

 

December 2019 to April 2022

 

April 2030

Rochester, NY

 

Office/Laboratory

 

3,000

 

January 2022

 

January 2027

Bothell, WA

 

Office/Laboratory/Manufacturing

 

80,000

 

January 2023

 

January 2039

Throughout the term of each lease agreement, the Company is responsible for paying, in addition to base rent, certain operating costs, such as common area maintenance, taxes, utilities, and insurance. These additional charges are considered variable lease costs and are recognized in the period in which the costs are incurred.

The following table summarizes the Company’s lease costs:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

Operating lease cost

 

$

11,384

 

 

$

4,469

 

 

$

16,080

 

 

$

9,088

 

Short-term lease cost

 

 

918

 

 

 

1,189

 

 

 

1,981

 

 

 

2,551

 

Variable lease cost

 

 

2,169

 

 

 

2,088

 

 

 

3,995

 

 

 

4,102

 

Total lease cost

 

$

14,471

 

 

$

7,746

 

 

$

22,056

 

 

$

15,741

 

As of June 30, 2025, the weighted-average remaining lease term was 7.4 years, and the weighted-average incremental borrowing rate was 10.9%.

The following table reconciles the Company’s undiscounted operating lease cash flows by fiscal year to the present value of the operating lease liabilities as of June 30, 2025 (in thousands):

 

2025 (remaining 6 months)

 

$

10,947

 

2026

 

 

22,473

 

2027

 

 

19,390

 

2028

 

 

14,698

 

2029

 

 

14,071

 

2030 and thereafter

 

 

48,700

 

Total undiscounted lease payments

 

 

130,279

 

Less: imputed interest

 

 

(44,787

)

Present value of operating lease liabilities

 

 

85,492

 

Less: current portion of operating lease liabilities

 

$

(13,832

)

Operating lease liabilities, net of current portion

 

$

71,660